Last edition
News about "metastatic pancreatic cancer treatment"
EMA Recommends Rasonque's Authorisation for Metastatic Pancreatic Cancer
EMA recommends authorisation of Rasonque for metastatic pancreatic cancer following a phased data review under its Cancer Medicines Pathfinder project.
Metastatic Pancreatic Cancer Treatment | 19/10/2026 | By News Bureau
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy
pharmaindustrial-india.com - Professional magazine for pharma industry suppliers and lab technology - CEDRO members